Endothelial dysfunction and fetuin A levels before and after kidney transplantation

Transplantation

Volumn 83, Issue 4, 2007, Pages 392-397

  Caglar, Kayser ^a   Yilmaz, Mahmut Ilker ^a   Saglam, Mutlu ^a   Cakir, Erdinc ^a   Kilic, Selim ^a   Eyileten, Tayfun ^a   Sonmez, Alper ^a   Oguz, Yusuf ^a   Oner, Koksal ^a   Ors, Fatih ^a   Vural, Abdulgaffar ^a   Yenicesu, Mujdat ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Endothelial dysfunction; Fetuin A; Kidney transplantation

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN A; FETUIN; FETUIN A; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PARATHYROID HORMONE; TACROLIMUS; UNCLASSIFIED DRUG; ALPHA2HS GLYCOPROTEIN; PLASMA PROTEIN;

ADULT; ARTERY INTIMA; ARTERY MEDIA; ARTICLE; BRACHIAL ARTERY; CAROTID ARTERY; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; FEMALE; GRAFT RECIPIENT; HUMAN; KIDNEY DONOR; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; PARATHYROID HORMONE BLOOD LEVEL; PRIORITY JOURNAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; ENDOTHELIUM; KIDNEY; METABOLISM; PATHOPHYSIOLOGY; VASCULARIZATION; VASODILATATION;

ADULT; BLOOD PROTEINS; ENDOTHELIUM; FEMALE; HUMANS; KIDNEY; KIDNEY TRANSPLANTATION; MALE; VASODILATION;

EID: 33947534592     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000251647.72673.c7     Document Type: Article

References (29)

1. Zoccali C, Mallamaci M, Tripepi G. Novel cardiovascular risk factors in end-stage renal disease. J Am Soc Nephrol 2004; 15: 577.
2. Suwaidi JA, Hamasaki S, Higano ST, et al. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation 2000; 101: 948.
3. Blacher J, Guerin AP, Pannier B, et al. Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension 2001; 38: 938.
4. Moe SM, O'Neill KD, Reslerova M, et al. Natural history of vascular calcification in dialysis and transplant patients. Nephrol Dial Transplant 2004; 19: 2387.
5. Floege J, Ketteler M. Vascular calcification in patients with end-stage renal disease. Nephrol Dial Transplant. 2004; 19: V59.
6. Heiss A, DuChesne A, Denecke B, et al. Structural basis of calcification inhibition by alpha 2-HS glycoprotein/fetuin-A. Formation of colloidal calciprotein particles. J Biol Chem 2003; 278: 13333.
7. Schafer C, Heiss A, Schwarz A, et al. The serum protein alpha 2-Heremans-Schmid glycoprotein/Fetuin-A is a systemically acting inhibitor of ectopic calcification. J Clin Invest 2003; 112: 357.
8. Stenvinkel P, Wang K, Qureshi AR, et al. Low Fetuin-A levels are associated with cardiovascular death: Impact of variations in the gene encoding fetuin. Kidney Int 2005; 67: 2383.
9. Ix JH, Chertow GM, Shlipak MG, et al. Fetuin-A and kidney function in persons with coronary artery disease-data from the heart and soul study. Nephrol Dial Transplant. 2006; 21: 2144.
10. Huang PH, Chen LC, Leu HB, et al. Enhanced coronary calcification determined by electron beam CT is strongly related to endothelial dysfunction in patients with suspected coronary artery disease. Chest 2005; 128: 810.
11. Levey AS, Bosch JP, Lewis JB, et al. A more accurate estimate of glomerular filtration rate from serum creatinine: A new prediction equition. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461.
12. Celermajer DS, Sorensen KE, Gooch VM, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992; 340: 1111.
13. Pignoli P, Tremoli E, Poli A, et al. Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation 1986; 74: 1399.
14. Bonetti PO, Lerman LO, Lerman A. Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol 2003; 23: 168.
15. Endemann DF, Schiffrin EL. Endothelial Dysfunction. J Am Soc Nephrol 2004; 15: 1983.
16. Yilmaz MI, Saglam M, Caglar K, et al. The determinants of endothelial dysfunction in CKD: oxidative stress and asymmetric dimethylarginine. Am J Kidney Dis 2006; 47: 42.
17. Perticone F, Maio R, Tripepi G, Zoccali C. Endothelial dysfunction and mild renal insufficiency in essential hypertension. Circulation 2004; 110: 821.
18. Ketteler M, Bongartz P, Westenfeld R, et al. Association of low Fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study. Lancet 2003; 361: 827.
19. Mehrotra R, Westenfeld R, Christenson P, et al. Serum Fetuin-A in nondialyzed patients with diabetic nephropathy: Relationship with coronary artery calcification. Kidney Int 2005; 67: 1070.
20. Moe SM, Reslerova M, Ketteler M, et al. Role of calcification inhibitors in the pathogenesis of vascular calcification in chronic kidney disease (CKD). Kidney Int 2005; 67: 2295.
21. Passauer J, Bussemaker E, Lassig G, Gross P. Kidney transplantation improves endothelium-dependent vasodilation in patients with endstage renal disease. Transplantation 2003; 75:1907.
22. Mark PB, Murphy K, Mohammed AS, et al. Endothelial dysfunction in renal transplant recipients. Transplant Proc 2005; 37: 3805.
23. Yilmaz MI, Saglam M, Caglar K, et al. Endothelial functions improve with decrease in asymmetric dimethylarginine (ADMA) levels after renal transplantation. Transplantation 2005; 80: 1660.
24. Mercanoglu F, Turkmen A, Kocaman O, et al. Endothelial dysfunction in renal transplant patients is closely related to serum cyclosporine levels. Transplant Proc 2004; 36: 1357.
25. Ketteler M. Fetuin-A and extraosseous calcification in uremia. Curr Opin Nephrol Hypertens 2005; 14: 337.
26. Martens FM, Rabelink TJ, Op't Roodt J, et al. TNF-[alpha] induces endothelial dysfunction in diabetic adults, an effect reversible by the PPAR-[gamma] agonist pioglitazone. Eur Heart J 2006; 27: 1605.
27. Ombrellino M, Wang H, Yang H, et al. Fetuin, a negative acute phase protein, attenuates TNF synthesis and the innate inflammatory response to carrageenan. Shock 2001; 15: 181.
28. Stefan N, Hennige AM, Staiger H, et al. Alpha2-Heremans-Schmid glycoprotein/Fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans. Diabetes Care 2006; 29: 853.
29. Voytovich MH, Asberg A, Hjelmesaeth J, et al. Association between insulin resistance and endothelial dysfunction in renal transplant recipients. Clin Transplant 2006; 20: 195.